Sponsor Pipeline

Shenzhen Fosun Kairos Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-14 NCT07765524 A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety… Phase 1/2 Not Yet Recruiting
2026-08-14 NCT07765537 A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07765524 A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety… Primary Light Chain (AL) Amyloidosis Not Yet Recruiting
NCT07765537 A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety… Primary Membranous Nephropathy Not Yet Recruiting
Early Phase 1
NCT07606937 A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma. Relapsed/Refractory Large B-cell Lymphoma Recruiting
Disease Areas
Amyloidosis (1)
Get alerts when Shenzhen Fosun Kairos Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free